clinical trial · NCT03563157
QUILT 3.071: NANT Colorectal Cancer (CRC) Vaccine
Colorectal Cancer MetastaticmCRCAldoxorubicin HydrochlorideALT-803ETBX-011ETBX-021ETBX-051ETBX-061GI-4000GI-6207
brief summary
QUILT 3.071 NANT Colorectal Cancer (CRC) Vaccine: This is a Phase 1b/2 study investigating the effect of NANT CRC vaccine vs regorafenib in subjects with CRC who were previously treated with SOC.
started
Sep 28, 2018
primary completion
Apr 21, 2019
completion
Aug 21, 2019
last updated
Dec 11, 2024
detailed description
NANT Colorectal Cancer (CRC) Vaccine: A phase 1b/2 Trial of the NANT CRC Vaccine vs Regorafenib in Subjects with Metastatic CRC Who Have Been Previously Treated with Standard-Of-Care Therapy
official title
NANT Colorectal Cancer (CRC) Vaccine: A Phase 1b/2 Trial of the NANT CRC Vaccine vs Regorafenib in Subjects With Metastatic CRC Who Have Been Previously Treated With Standard-of-Care Therapy
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol